Novartis Ag NVS
NYSE NVS
$140.98 -1.59 (-1.12%)
As of: Oct 1, 2026 · 3:59 PM EDT

Novartis Ag (NVS) Total Non-Current Liabilities (2009 - 2026)

Updated

Novartis Ag (NVS) posted Total Non-Current Liabilities of $48.34 billion for Q2 2026, up 57.8% from $30.63 billion a year earlier and up 0.2% from the prior quarter.

Analysis

Novartis Ag (NVS) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

At the end of FY2025, Novartis Ag's Total Non-Current Liabilities came in at $37.12 billion, up 26.1% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -0.5% (FY2020 to FY2025).
  • In prior years, Novartis Ag's Total Non-Current Liabilities was $29.43 billion in FY2024 (+9.8%), $26.81 billion in FY2023 (-8.7%), $29.37 billion in FY2022 (-13.0%) and $33.77 billion in FY2021 (-11.3%).
  • The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities in data going back to Q1 2009.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last three quarters, with growth averaging 25.1% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q1 2026, with growth of 61.5%; the weakest was Q3 2021, with a decline of 20.5%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $48.23 billion (Q1 2026), $37.12 billion (Q4 2025) and $30.54 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn 60.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 48.34 Bn
Mar 31, 2026 48.23 Bn
Dec 31, 2025 37.12 Bn
Sep 30, 2025 30.54 Bn
Jun 30, 2025 30.63 Bn
Mar 31, 2025 29.87 Bn
Dec 31, 2024 29.43 Bn
Sep 30, 2024 31.95 Bn
Jun 30, 2024 27.99 Bn
Mar 31, 2024 25.29 Bn
Dec 31, 2023 26.81 Bn
Sep 30, 2023 26.06 Bn
Jun 30, 2023 27.14 Bn
Mar 31, 2023 29.55 Bn
Dec 31, 2022 29.37 Bn
Sep 30, 2022 29.41 Bn
Jun 30, 2022 32.26 Bn
Mar 31, 2022 -12.00 Mn
Dec 31, 2021 33.77 Bn
Sep 30, 2021 34.39 Bn
API Access

Novartis Ag Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=NVS&period=max&api_key=YOUR_API_KEY